Overall, our in vitro results have demonstrated that ALA can affect two cellular pathways playing a significant role in the progression of prostate carcinoma: Nrf2/Keap1/p62 and autophagy machinery, as recently highlighted in the literature [6,49]. The gene discussed is SQSTM1; the disease is prostate carcinoma.